CTC BIO, INC.
CTC Bio develops veterinary and human medicines using fermentation and drug-delivery technology, including CTCZYME and a CBD oral film.
Price
Change
Market cap
Business overview
Source: DART corporate disclosureFounded in 1995, CTC Bio listed on KOSDAQ in 2002 as a company spanning veterinary and human pharmaceuticals. Using fermentation and drug delivery system (DDS) technology, it developed CTCZYME, winner of a World Class Product award and the Jang Yeong-sil Award, along with oral dissolving films (ODF) and combination drugs; its animal-health division supplies feed additives, disinfectants, and vaccines, while its human-health division offers improved new drugs, generics, and health functional foods. It commercialized 'Vectorphage A', a bacteriophage-based product to control bacterial disease at olive flounder farms (7/5 domestic patent applications/registrations, 15 strain deposits), and developed a high-dose, high-bioavailability CBD oral dissolving film versus Epidiolex®, transferring manufacturing technology to German CMO Vektor GmbH and completing pilot-scale batch production.
Products & technology
- CTCZYME
- 벡터페이즈 A
Regulatory approvals
data.go.kr124 Korean MFDS drug approvals · 2006–2024 / 3 Korean MFDS device approvals · 2020–2022
- MFDS drugCinexin Tab. 240mg2024-11-28Drug · OTC · Notification202402823
- MFDS drugOne-two tab.2024-09-09Drug · Prescription · Approval202402179
- MFDS drugReal GLUTATHIONE Orodispersible Film 100mgRevoked2024-08-28Drug · OTC · Approval202402079
- MFDS drugENUF Orodispersible Film 100mg2024-06-19Drug · Prescription · Approval202401479
- MFDS drugOne-two tab.2024-05-16Drug · Prescription · Approval202401189
- MFDS drugCT On Tab. 30mg2024-02-29Drug · Prescription · Approval202400422
- MFDS drugCTCBIO Gluthathione orodispersible film 105mgRevoked2024-02-16Drug · OTC · Approval202400342
- MFDS drugDuyzen Tab. 60/5mg(Fimasartan Potassium Trihydrate/S-Amlodipine besylate)Revoked2023-01-06Drug · Prescription · Approval202300104
- MFDS drugDuyzen Tab. 60/2.5mg(Fimasartan Potassium Trihydrate/S-Amlodipine besylate)Revoked2023-01-06Drug · Prescription · Approval202300121
- MFDS drugDuyzen Tab. 30/2.5mg(Fimasartan Potassium Trihydrate/S-Amlodipine besylate)Revoked2023-01-06Drug · Prescription · Approval202300137
- MFDSTool for specimensRevoked2022-05-26Product approval · Class 1수신 22-929 호
- MFDSTool for specimensRevoked2022-04-13Product approval · Class 1제신 22-492 호
Show 68 more
- MFDS drugEsoriumPlus Tab. 20/800mg2021-06-14Drug · Prescription · Approval202104524
- MFDS drugNicobreak Orodispersible Film 1mg (Varenicline salicylate)Revoked2021-04-13Drug · Prescription · Approval202103088
- MFDS drugNicobreak Orodispersible Film 0.5mg (Varenicline salicylate)Revoked2021-04-13Drug · Prescription · Approval202103089
- MFDS drugArotinplus tablet 10/40mg(Ezetimibe/Atorvastatin calcium trihydrate)2021-02-18Drug · Prescription · Approval202101484
- MFDS drugArotinplus tablet 10/20mg(Ezetimibe/Atorvastatin calcium trihydrate)2021-02-18Drug · Prescription · Approval202101485
- MFDS drugArotinplus tablet 10/10mg(Ezetimibe/Atorvastatin calcium trihydrate)2021-02-18Drug · Prescription · Approval202101486
- MFDS drugAllerno Orodispersible Film(Loratadine)Revoked2020-08-28Drug · OTC · Notification202006062
- MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), immunological methodRevoked2020-05-21Product approval · Class 3체외 제허 20-384 호
- MFDS drugSaporelly SR Tab. 300mg2020-05-21Drug · Prescription · Approval202003676
- MFDS drugPregaba Cap. 25mg2020-05-19Drug · Prescription · Approval202003631
- MFDS drugPregaba Cap. 50mg2020-05-19Drug · Prescription · Approval202003632
- MFDS drugSaporelly Tab. 100mg2020-05-13Drug · Prescription · Approval202003458
- MFDS drugC-chroquine Tab. 400mg (for export)2020-05-12Drug · Prescription · Approval202003433
- MFDS drugC-chroquine Tab. 200mg (for export)2020-05-12Drug · Prescription · Approval202003434
- MFDS drugC-chroquine Tab. 100mg (for export)2020-05-12Drug · Prescription · Approval202003435
- MFDS drugTrabit Semi SR Tab.2020-05-08Drug · Prescription · Approval202003336
- MFDS drugTrabit SR Tab.2020-05-08Drug · Prescription · Approval202003337
- MFDS drugEcetal SR Tab.2020-04-29Drug · Prescription · Approval202003194
- MFDS drugRemecept Tab. 10mg2020-03-24Drug · Prescription · Approval202002049
- MFDS drugRemecept Tab. 5mg2020-03-24Drug · Prescription · Approval202002058
- MFDS drugTiciren Tab.Revoked2019-12-31Drug · Prescription · Notification201908717
- MFDS drugEasy Flu Powder 30mg2019-10-28Drug · Prescription · Approval201907513
- MFDS drugEasy Flu Powder 45mg2019-10-28Drug · Prescription · Approval201907514
- MFDS drugEasy Flu Powder 75mg2019-10-28Drug · Prescription · Approval201907515
- MFDS drugCelcoxbrex Cap. 200mg2019-09-11Drug · Prescription · Approval201906422
- MFDS drugCave-CT Tab. 25mg2019-08-07Drug · Prescription · Approval201905581
- MFDS drugCave-CT Tab. 12.5mg2019-08-07Drug · Prescription · Approval201905582
- MFDS drugGODN Tab. 10mg2019-05-21Drug · Prescription · Approval201903302
- MFDS drugGODN Tab. 20mg2019-05-21Drug · Prescription · Approval201903303
- MFDS drugJinnetil Tab. 250mg2019-04-17Drug · Prescription · Approval201902352
- MFDS drugMomeCT Nasal Spray Solution2019-03-04Drug · Prescription · Notification201901320
- MFDS drugNose Quick Orodispersible FilmRevoked2018-12-07Drug · OTC · Notification201804948
- MFDS drugMoktein Cap.Revoked2018-11-08Drug · OTC · Notification201804440
- MFDS drugThioctason Tab.Revoked2018-10-31Drug · Prescription · Approval201804313
- MFDS drugClorac Tab.2018-08-21Drug · Prescription · Approval201803418
- MFDS drugNicobreak Tab. 0.5mg2018-08-14Drug · Prescription · Approval201803328
- MFDS drugNicobreak Tab. 1mg2018-08-14Drug · Prescription · Approval201803337
- MFDS drugC-tos Tab.2018-06-27Drug · Prescription · Approval201802670
- MFDS drugCT ryl Tab.2018-05-21Drug · Prescription · Approval201802132
- MFDS drugCTcin Tab.2018-04-30Drug · Prescription · Approval201801841
- MFDS drugCT Gaba Cap. 100mg2018-04-30Drug · Prescription · Approval201801845
- MFDS drugCT Gaba Cap. 300mg2018-04-30Drug · Prescription · Approval201801846
- MFDS drugTaliad Tab.2018-02-28Drug · Prescription · Approval201800999
- MFDS drugMucomipide Tab.2017-07-20Drug · Prescription · Approval201705772
- MFDS drugBabrone Tab. 10mg2017-07-20Drug · Prescription · Approval201705785
- MFDS drugBabrone Tab. 5mg2017-07-20Drug · Prescription · Approval201705786
- MFDS drugMonteloss Tab. 10mg2017-07-20Drug · Prescription · Approval201705792
- MFDS drugMonteros Chewable Tab. 5mg2017-06-30Drug · Prescription · Approval201705154
- MFDS drugMonteros Chewable Tab. 4mg2017-06-30Drug · Prescription · Approval201705155
- MFDS drugPregaba Cap. 150mg2017-05-29Drug · Prescription · Approval201702684
- MFDS drugPregaba Cap. 75mg2017-05-29Drug · Prescription · Approval201702685
- MFDS drugEasy Flu Cap. 75mg2017-05-26Drug · Prescription · Approval201702618
- MFDS drugSafrep Sol.2016-10-06Drug · Prescription · Approval201605940
- MFDS drugDualsartan Tab. 40/10mg2016-09-30Drug · Prescription · Approval201605742
- MFDS drugDualsartan Tab. 40/5mg2016-09-30Drug · Prescription · Approval201605743
- MFDS drugDualsartan Tab. 80/5mg2016-09-30Drug · Prescription · Approval201605744
- MFDS drugLiconazole Tab.2016-06-24Drug · Prescription · Approval201603868
- MFDS drugAldmac Plus D Tab.2016-06-23Drug · Prescription · Approval201603802
- MFDS drugRaprazole Tab. 20mg2016-06-23Drug · Prescription · Approval201603803
- MFDS drugRaprazole Tab. 10mg2016-06-23Drug · Prescription · Approval201603804
- MFDS drugUrodart Soft Cap. 0.5mg2016-06-21Drug · Prescription · Approval201603673
- MFDS drugAd-S Tab.2016-06-21Drug · Prescription · Approval201603676
- MFDS drugRexamel Tab. 20mg2016-06-21Drug · Prescription · Approval201603695
- MFDS drugRexamel Tab. 10mg2016-06-21Drug · Prescription · Approval201603696
- MFDS drugAmorex Tab. 375mg2016-06-20Drug · Prescription · Approval201603597
- MFDS drugAmorex Tab. 625mg2016-06-20Drug · Prescription · Approval201603598
- MFDS drugUraid Tab.2016-06-20Drug · Prescription · Approval201603616
- MFDS drugLevotri Tab.Revoked2016-06-17Drug · Prescription · Approval201603575
Showing the 80 most recent of 127 records.
Clinical trials
data.go.kr36 MFDS clinical trial authorisations · 2012–2023 (Bioequivalence 20 · Phase 1 13 · Phase 3 2 · Phase 2 1)
- Bioequivalence씨티씨니세르골린정30mg(가칭)(니세르골린)2023-05-15
2 trial sites
- Bioequivalence듀얼살탄정80/5밀리그램(텔미사르탄, 암로디핀)2021-12-31
2 trial sites
- Bioequivalence몬테로스정10mg(몬테루카스트나트륨)2021-10-18
2 trial sites
- Bioequivalence고든정20mg(타다라필)2021-08-06
2 trial sites
- Bioequivalence라프라졸정20mg2021-08-02
1 trial site
- Bioequivalence아로틴정20mg(아토르바스타틴칼슘삼수화물)2020-12-01
2 trial sites
- BioequivalenceCDFG05182020-07-24
2 trial sites
- BioequivalenceCDFF0218(가칭)2020-07-01
1 trial site
- Bioequivalence고든정20mg(타다라필)2019-11-06
1 trial site
- Bioequivalence클로첸스정(클로피도그렐황산염)2019-09-23
2 trial sites
- Phase 1CDFF03182019-03-11
1 trial site
- Phase 3CDFR08122019-03-05
22 trial sites
Show 24 more
- BioequivalenceCDFF0817(가칭)2019-02-27
2 trial sites
- BioequivalenceCDFF0717(가칭)2018-11-27
2 trial sites
- BioequivalenceCDFF0712 (가칭)2018-11-27
2 trial sites
- BioequivalenceCDFR03172018-11-27
2 trial sites
- Bioequivalence로바이드정20mg(로수바스타틴칼슘)2018-06-07
2 trial sites
- Bioequivalence메디솔론정(메틸프레드니솔론)2018-01-24
3 trial sites
- Phase 1CDFR02162017-05-15
1 trial site
- BioequivalenceCDFF0113(가칭)2016-11-25
2 trial sites
- Phase 2CDFR08122015-04-15
16 trial sites
- BioequivalenceCDFR01142014-10-24
2 trial sites
- Phase 1CDFF05112014-07-23
1 trial site
- Phase 1CDFF05112014-07-01
1 trial site
- BioequivalenceCTC둘록세틴캡슐60mg(가칭)(둘록세틴염산염)2014-06-12
2 trial sites
- Bioequivalence듀레신구강용해필름0.2mg(데스모프레신아세트산염)2014-06-09
2 trial sites
- Phase 3CDFR0613(가칭), CDFR0612(가칭)2014-04-29
4 trial sites
- Phase 1CDFR02092013-11-18
1 trial site
- Phase 1컨덴시아정15밀리그램(클로미프라민염산염), 비아그라정100밀리그람(구연산실데나필)2013-11-05
1 trial site
- Phase 1CDFF02132013-08-01
1 trial site
- Phase 1CDFF02132013-07-31
1 trial site
- Phase 1CDFF06122013-06-19
1 trial site
- Phase 1CDFF06122013-06-18
1 trial site
- Phase 1CDFR01112013-05-10
1 trial site
- Phase 1CDFF02122013-02-27
1 trial site
- Phase 1플리즈구강용해필름50밀리그램(실데나필)2012-08-02
1 trial site
R&D and key agreements
Source: DART corporate disclosureCBD 구강용해필름 · 뇌전증 등(Epidiolex® 대비 고용량 CBD 제형) · 제조기술 이전 및 pilot scale batch 생산 완료 · Participated in Gyeongbuk Hemp Regulation-Free Zone project, established Andong Research Institute (task No. P0016082). Solubilization technology achieved higher CBD content and bioavailability equal to or better than Epidiolex®; manufacturing technology transferred to German CMO Vektor GmbH; 3 patents (solubilization, stability, manufacturing method) filed
호흡기 병원성 제어 박테리오파지 · 호흡기 병원성 제어 · 제품화 연구 진행 중 · Isolated bacteriophages with multiple strain deposits and patents secured
Companies approved for the same productsPharma & CDMO
Ranked by how many MFDS product categories overlap. Not a ranking — a pointer to where to look.
KOSDAQ-listed point-of-care immunodiagnostics company supplying diagnostic cartridges and the ichroma/AFIAS instrument series.
Holds manufacturing approvals for 42 point-of-care diagnostic reagents and devices in the IVD market.
GC Medical Science Corporation, KOSDAQ-listed since 2014, operates diagnostic reagent, blood glucose, and hemodialysis solution businesses.
KOSDAQ-listed IVD company producing COVID-19 and HIV point-of-care diagnostic reagents alongside rubber products and entertainment businesses.
Founded in 1999 and listed on KONEX in 2017, Median Diagnostics develops and manufactures immunoassay, molecular, and point-of-care in vitro diagnostic kits for animal diseases.
Founded in 1987 and listed on KOSDAQ in 2000, NanoenTek develops Lab-On-a-Chip in-vitro diagnostic devices and life science instruments.
Founded 1996, listed on KOSDAQ in 2024, OSANG HEALTHCARE develops and sells biochemistry, immunodiagnostic, and molecular IVD products.
KOSDAQ-listed IVD company using SG Cap™ multiplex diagnostic technology for infectious disease, cancer, and companion animal testing.
KOSDAQ-listed IVD company producing time-resolved fluorescence immunodiagnostic products under the Exdia TRF brand.
KOSDAQ-listed in-vitro diagnostics company developing the LabChip-based VERI-Q molecular diagnostic device series.
KOSPI-listed in-vitro diagnostics company known for the STANDARD Q antigen/antibody test kits.
Founded in 2011 and KOSDAQ-listed in 2019, Sugentech develops multiplex immunoblot, point-of-care, and digital healthcare diagnostics.
Sources and updates
- Company basics
- Korea Exchange · DART
- Business content
- Compiled from disclosure filings
- AI visibility
- Measured 2026-08-13
This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.
Request a correction or addition